- Home
- APLD vs PCRX Comparison
APLD vs PCRX Comparison
Compare APLD & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLD
- PCRX
- Stock Information
- Founded
- APLD 2001
- PCRX 2006
- Country
- APLD United States
- PCRX United States
- Employees
- APLD N/A
- PCRX N/A
- Industry
- APLD Investment Bankers/Brokers/Service
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- APLD Finance
- PCRX Health Care
- Exchange
- APLD Nasdaq
- PCRX Nasdaq
- Market Cap
- APLD 1.3B
- PCRX 1.2B
- IPO Year
- APLD N/A
- PCRX 2011
- Fundamental
- Price
- APLD $5.61
- PCRX $24.65
- Analyst Decision
- APLD Strong Buy
- PCRX Buy
- Analyst Count
- APLD 9
- PCRX 9
- Target Price
- APLD $10.67
- PCRX $29.89
- AVG Volume (30 Days)
- APLD 35.3M
- PCRX 870.2K
- Earning Date
- APLD 04-14-2025
- PCRX 05-08-2025
- Dividend Yield
- APLD N/A
- PCRX N/A
- EPS Growth
- APLD N/A
- PCRX N/A
- EPS
- APLD N/A
- PCRX N/A
- Revenue
- APLD $221,192,000.00
- PCRX $702,772,000.00
- Revenue This Year
- APLD $32.84
- PCRX $9.48
- Revenue Next Year
- APLD N/A
- PCRX $11.31
- P/E Ratio
- APLD N/A
- PCRX N/A
- Revenue Growth
- APLD 53.70
- PCRX 3.08
- 52 Week Low
- APLD $3.01
- PCRX $11.16
- 52 Week High
- APLD $12.48
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- APLD 56.02
- PCRX 46.69
- Support Level
- APLD $5.24
- PCRX $23.23
- Resistance Level
- APLD $6.28
- PCRX $26.26
- Average True Range (ATR)
- APLD 0.40
- PCRX 1.25
- MACD
- APLD 0.18
- PCRX -0.25
- Stochastic Oscillator
- APLD 74.03
- PCRX 37.67
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments; Data Center Hosting Business, Cloud Services Business, and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business which operates data centers to provide energized space to crypto mining customers.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.